1887

Chapter 18 : Treatment of Eye Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Treatment of Eye Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap18-1.gif /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap18-2.gif

Abstract:

The quinolone antimicrobials are commonly prescribed as eye drops for the therapy of anterior eye infections such as conjunctivitis and keratitis. Ophthalmic drops containing 3 mg of norfloxacin, ciprofloxacin, ofloxacin, and levofloxacin per ml (0.3% solutions) are available. Bacterial infections of the eye and contiguous tissues include conjunctivitis, keratitis, blepharitis, preseptal cellulitis, orbital cellulitis, cavernous sinus thrombosis, uveitis, and endophthalmitis. The discussion in this chapter is limited to the use and pharmacology of quinolones for the treatment of bacterial infections of the conjunctiva (conjunctivitis), cornea (keratitis), and aqueous and vitreous humors (endophthalmitis). Conjunctivitis is the most common bacterial infection of the eye and is also often caused by viruses. Although it causes local symptoms including irritation and tearing, it is rarely sight threatening and often resolves without antimicrobial therapy. Treatment of keratitis requires antibiotic penetration into the corneal stroma, and endophthalmitis requires penetration into the aqueous and vitreous humors. Pharmacodynamic models characterize the relationship between antimicrobial drug exposure and activity, expressed as the MIC, with efficacy or drug exposure with toxicity. The pharmacokinetics of intravitreal quinolones has been characterized for fleroxacin, ciprofloxacin, ofloxacin, and sparfloxacin. Lipophilic quinolones such as ofloxacin, levofloxacin, and sparfloxacin show good penetration into the vitreous humor following systemic drug administration even in the absence of inflammation.

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Relationship between the partition coefficient for ciprofloxacin (Cipro), fleroxacin (Flero), ofloxacin (Oflo), levofloxacin (Levo), and sparfloxacin (Spar) and the relative penetration into the vitreous humor.

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817817.chap18
1. Akkan, A. G.,, I. Mutlu,, S. Ozyazgan,, A. Gok,, U. Yigit,, Z. Ozuner,, V. Senses,, and H. Pekel. 1997. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye. J. Chemother. 9:257262.
2. Alexandrakis, G.,, R. Haimovici,, D. Miller,, and E. C. Alfonso. 2000. Corneal biopsy in the management of progressive microbial keratitis. Am. J. Ophthalmol. 129:571576.
3. Alfaro, D. V.,, J . Davis,, S. Kim,, F. Bia,, J. F. Bogard,, J. W. Briggs,, and P. E. Liggett. 1996. Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin. Br. J. Ophthalmol. 80:755758.
4. Alfaro, D.V., III,, S. J. Hudson,, J. J. Offele,, A. A. Bevin,, M. Mines,, R. M. Laughlin,, and R. J. Schoderbek. 1996. Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. Retina 16:317323.
5. Alfaro, D. V.,, S. J. Hudson,, M. M. Rafanan,, S. T. Moss,, and S. D. Levy. 1996. The effect of trauma on the ocular penetration of intravenous ciprofloxacin. Am. J. Ophthalmol. 122:678683.
6. Assil, K. K.,, S. R. Zarnegar,, B. D. Fouraker,, and D. J. Schanzlin. 1992. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas-aeruginosa-induced keratitis in rabbits. Am. J. Ophthalmol. 113:418423.
7. Ball, P. 1986. Ciprofloxacin: an overview of adverseexperiences.J. Antimicrob. Chemother. 18(Suppl.D):187193.
8. Ball, P. 1989. Adverse reactions and interactions of fluoroquinolones. Clin. Investig. Med. 12:2834.
9. Barza, M.,, J. Baum,, W. Taseman,, and E. A. Jaeger,. 2000. Ocular pharmacology of antibiotics. In W. Tasman, and E. A. Jaeger (ed.), Duane's Clinical Ophthalmology on CD ROM. Lippincott Williams & Wilkins, Philadelphia, Pa.
10. Barza, M., 1993. Treatment of eye infections, p. 423434. In D. C. Hooper, and J. S. Wolfson (ed.), Quinolone Antimicrobial Agents, 2nd ed. American Society for Microbiology, Washington, D.C.
11. Barza, M.,, A. Kane,, and J. Baum. 1982. The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Investig. Ophthalmol. Vis. Sci. 22:720726.
12. Behrens-Baumann, W. 1996. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye. Ophthalmologica 210:119122.
13. Behrens-Baumann, W.,, and J . Martell. 1987. Ciprofloxacin concentrations in human aqueous humor following intravenous administration. Chemotherapy 33:328330.
14. Behrens-Baumann, W.,, and J . Martell. 1988. Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration. Infection 16:5457.
15. Bito, L.,, and C. DeRousseau,. 1980. Transport functions of the blood-retinal barrier system and the micro-environment of the retina, p. 33163. In J. G. Cunha-Vaz (ed.), NATO Advanced Study Institute Series. Plenum Press, New York, N. Y.
16. Brennen, C.,, and R. R. Muder. 1990. Conjunctivitis associated with methicillin-resistant Staphylococcus aureus in a long-term-care facility. Am. J. Med. 88:14N17N.
17. Bron, A.,, D. Talon,, T. Cellier,, J . M. Estavoyer,, B. Delbose,, and J . Rover. 1989. [Intra aqueous humor penetration of ciprofloxacin in humans]. Pathol. Biol. 37:730733.
18. Bron, A.,, D. Talon,, B. Delbose,, J . M. Estavoyer,, G. Kaya,, and J . Royer. 1987. [Intracameral penetration of ofloxacin in man]. J . Fr. Ophtalmol. 10:443446.
19. Bron, A.,, D. Talon,, B. Delbose,, J. M. Estavoyer,, F. Prost,, and M. Montard. 1986. [Intracameral penetration of pefloxacine in man].J. Fr. Ophtalmol. 9:317321.
20. Bron, A.,, D. Talon,, J. M. Estavoyer,, T. Cellier,, B. Delbose,, and M. Montard. 1989. Ocular distribution of the new quinolones. Rev. Infect. Dis. 11 (Suppl. 5):S1206S1207.
21. Bron, A. M.,, A. P. Pechinot,, C. P. Garcher,, G. A. Guyonnet,, A. M. Kazmierczak,, D. A. Schott,, and H. Lecoeur. 1994. The ocular penetration of oral sparfloxacin in humans. Am. J. Ophthalmol. 117:322327.
22. Burns-Bellhorn, M. S.,, R. W. Bellhorn,, and J. V. Benjamin. 1978. Anterior segment permeability to fluorescein-labeled dextrans in the rat. Investig. Ophthalmol. Vis. Sci. 17:857862.
23. Cantor, L. B.,, E. Donnenfeld,, L. J. Katz,, W. L. Gee,, C. D. Finley,, V. K. Lakhani,, J . Hoop,, and K. Flarty. 2001. Penetration of ofloxacin and ciprofloxacin into the aqueous humor of eyes with functioning filtering blebs: a randomized trial. Arch. Ophthalmol. 119:12541257.
24. Cekic, O.,, C. Batman,, Y. Totan,, U. Yasar,, N. E. Basci,, A. Bozkurt,, and S. O. Kayaalp. 1999. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration. Ophthal. Surg. Lasers 30:465468.
25. Cekic, O.,, C. Batman,, Y. Totan,, U. Yasar,, N. E. Basci,, A. Bozkurt,, S. O. Kayaalp,, and O. Zilelioglu. 1999. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye 13 (Pt. 5):656659.
26. Cekic, O.,, C. Batman,, U. Yasar,, N. E. Basci,, A. Bozkurt,, and S. O. Kayaalp. 1998. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina 18:521525.
27. Cekic, O.,, C. Batman,, U. Yasar,, N. N. E. Basci,, A. Bozkurt,, and S. O. Kayaalp. 1999. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration. Eye 13 (Pt. 4):555558.
28. Cekic, O.,, C. Batman,, U. Yasar,, N. E. Basci,, O. Zilelioglu,, and A. Bozkurt. 2000. Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans. Br. J. Ophthalmol. 84:10611063.
29. Celebi, S.,, S. Ay,, U. Aykan,, V. Bulut,, G. Alagoz,, and U. O. Celiker. 1998. Penetration of oral and topical ciprofloxacin into human aqueous humor. Acta Ophthalmol. Scand. 76:683685.
30. Christ, W.,, and T. Lehnert,. 1990. Toxicity of the quinolones, p. 165187. In C. Siporin,, C. L. Heifetz,, and J. M. Domagala (ed.), The New Generation of Quinolones. Marcel Dekker, Inc., New York, N. Y.
31. Christ, W.,, T. Lehnert,, and B. Ulbrich. 1988. Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10 (Suppl. 1):S141S146.
32. Cochereau-Massin, I.,, J. Bauchet,, F. Faurisson,, J. M. Vallois,, P. Lacombe,, and J. J. Pocidalo. 1991. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrob. Agents Chemother. 35:11121115.
33. Cochereau-Massin, I.,, J. Bauchet,, S. Marrakchi-Benjaafar,, A. Saleh-Mghir,, F. Faurisson,, J. M. Vallois,, E. Vallee,, and J. J. Pocidalo. 1993. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrob. Agents Chemother. 37:633636.
34. Cochereau-Massin, I.,, S. Marrakchi-Benjaafar,, J . Bauchet,, J. M. Vallois,, F. Faurisson,, F. D'Hermies,, and J. J. Pocidalo. 1994. Kinetics and tolerability of intravitreal pefloxacin in rabbits. J. Antimicrob. Chemother. 33:231242.
35. Cohen, R. G.,, M. Raizman,, C. Callina,, and M. Lahav. 1997. Retinal safety of oral and topical ofloxacin in rabbits. J. Ocul. Pharmacol. Ther. 13:369379.
36. Corrado, M. L.,, W. E. Struble,, C. Peter,, V. Hoagland,, and J . Sabbaj. 1987. Norfloxacin: review of safety studies. Am. J. Med. 82:2226.
37. Davey, P. G.,, M. Barza,, and M. Stuart. 1987. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.J. Infect. Dis. 155:518523.
38. Davson, H.,, and M. B. Segal. 1969. Effect of cerebrospinal fluid on volume of distribution of extracellular markers. Brain 92:131136.
39. Denis, F.,, M. Mounier,, and J. P. Adenis. 1987. [Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body]. Pathol. Biol. 35:772776.
40. Donnenfeld, E. D.,, H. D. Perry,, R. W. Snyder,, R. Moadel,, M. Elsky,, and H. Jones. 1997. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch. Ophthalmol. 115:173176.
41. Drusano, G. L. 2000. Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome. J . Chemother. 12(Suppl.) 4:2126.
42. Drusano, G. L.,, and W. A. Craig. 1997. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J. Chemother. 9:3844.
43. Drusano, G. L.,, D. E. Johnson,, M. Rosen,, and H. C. Standiford. 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob. Agents Chemother. 37:483490.
44. Drusano, G. L.,, W. Liu,, R. Perkins,, A. Madu,, C. Madu,, M. Mayers,, and M. H. Miller. 1995. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents Chemother. 39:16831687.
45. Durmaz, B.,, S. Marol,, R. Durmaz,, O. Oram,, I. F. Hepsen,, and S. Gunal. 1997. Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin. Arzneim.-forsch. 47:413415.
46. Eiferman, R. A.,, J. P. Snyder,, and R. E. Nordquist. 2001. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J. Cataract Refract. Surg. 27:17011702.
47. el Baba, F. Z.,, M. D. Trousdale,, W. J. Gauderman,, D. G. Wagner,, and P. E. Liggett. 1992. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 99:483486.
48. Elmquist, W. F.,, and R. J. Sawchuk. 1997. Application of microdialysis in pharmacokinetic studies. Pharm. Res. (N. Y.) 14:267288.
49.Endophthalmitis Vitrectomy StudyGroup. 1995. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch. Ophthalmol. 113:14791496.
50. Engel, L. S.,, M. C. Callegan,, J. M. Hill,, A. T. Folkens,, Y. Shimomura,, and R. J. O'Callaghan. 1996. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn. J. Ophthalmol. 40:212219.
51. Esposito, S.,, H. Thadepalli,, H. A. Benler,, and S. K. Chuah. 1991. Enoxacin therapy for experimental pseudomonas keratitis.J. Chemother. 3:147151.
52. Fern, A. I.,, G. Sweeney,, M. Doig,, and G. Lindsay. 1986. Penetration of ciprofloxacin into aqueous humor. Trans. Ophthalmol. Soc. U. K. 105(Pt. 6):650652.
53. Fiscella, R. G.,, T. K. Nguyen,, M. J. Cwik,, B. A. Phillpotts,, S. M. Friedlander,, D. C. Alter,, M. J. Shapiro,, N. P. Blair,, and J . P. Gieser. 1999. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology 106:22862290.
54. Gangopadhyay, N.,, M. Daniell,, L. Weih,, and H. R. Taylor. 2000. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br. J. Ophthalmol. 84:378384.
55. Ghelardi, E.,, A. Tavanti,, F. Celandroni,, A. Lupetti,, C. Blandizzi,, E. Boldrini,, M. Campa,, and S. Senesi. 2000. Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits. J . Antimicrob. Chemother. 46:831834.
56. Gritz, D. C.,, P. J. McDonnell,, T. Y. Lee,, D. Tang-Liu,, B. B. Hubbard,, and A. Gwon. 1992. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Cornea 11:143147.
57. Gurler, B.,, Y. Ozkul,, M. Bitiren,, A. Satici,, H. Oguz,, and S. Karadede. 2001. Experimental intravitreal application of trovafloxacin in rabbits. Ophthalmic Res. 33:228236.
58. Habgood, M. D.,, D. J. Begley,, and N. J. Abbott. 2000. Determinants of passive drug entry into the central nervous system. Cell. Mol. Neurobiol. 20:231253.
59. Hainsworth, D. P.,, J \. D. Conklin,, J. R. Bierly,, D. Ax,, and P. Ashton. 1996. Intravitreal delivery of ciprofloxacin. J. Ocul. Pharmacol. Ther. 12:183191.
60. Hanioglu-Kargi, S.,, N. Basci,, H. Soysal,, A. Bozkurt,, E. Gursel,, and O. Kayaalp. 1998. The penetration of ofloxacin into human aqueous humor given by various routes. Eur. J. Ophthalmol. 8:3336.
61. Hatano, H.,, K. Inoue,, S. Shia,, and W. Liping. 1993. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. Acta Ophthalmol. 71:666670.
62. Hobden, J. A.,, J. J. Reidy,, R. J. O'Callaghan,, M. S. Insler,, and J . M. Hill. 1990. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Investig. Ophthalmol. Vis. Sci. 31:22412243.
63. Hughes, P. M.,, R. Krishnamoorthy,, and A. K. Mitra. 1996. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 12:209224.
64. Hulem, C. D.,, S. E. Old,, L. D. Zeleznick,, and I. H. Leopold. 1982. Intraocular penetration of rosoxacin in rabbits. Arch. Ophthalmol. 100:646649.
65. Hurault deLigny, B.,, D. Sirbat,, M. Kessler,, P. Trechot,, and J. Chanliau. 1984. [Ocular side effects of flumequine. 3 cases of macular involvement]. Therapie 39:595600.
66. Insler, M. S.,, L. A. Fish,, J. Silbernagel,, J. A. Hobden,, R. J. O'Callaghan,, and J. M. Hill. 1991. Successful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology 98:16901692.
67. Jacobson, J. A.,, N. B. Call,, E. M. Kasworm,, M. S. Dirks,, and R. B. Turner. 1988. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections. Antimicrob. Agents Chemother. 32:18201824.
68. Jaehde, U.,, F. Sorgel,, A. Reiter,, G. Sigl,, K. G. Naber,, and W. Schunack. 1995. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin. Pharmacol. Ther. 58:532541.
69. Janert, B.,, B. Schull,, and H. P. Geisen. 1989. Concentrations of ciprofloxacin in aqueous humor following intravenous and oral administration. Rev. Infect. Dis. 11(Suppl. 5) S1077.
70. Joos, B.,, F. Gassman,, and R. Luthy. 1986. Penetration of ciprofloxacin into the human eye. In Program and Abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
71. Jumbe, N.,, W. Liu,, G. Drusano,, A. Louie,, and M. H. Miller. 1999. Comparison of Quinolone active efflux afer, systemic, intravitreous and intracerebrovascula administration. In Program and Abstracts of the 39th Interscience Conference on Amtimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
72. Jumbe, N.,, W. Liu,, A. Louie,, G. Drusano,, and M. H. Miller. 1999. Parametric comparison of microdialysis and direct vitreous sampling techniques at non-steady-state conditions. In Program and Abstracts of the 39th Interscience Conference of Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D. C.
73. Kalayci, D.,, N. Basci,, S. Kortunay,, H. Hasiripa,, and A. Bozkurt. 1999. Penetration of Topical ciprofloxacin by presoaked medicated soft contact lenses. CLAO J. 25:192184.
74. Karakucuk, S.,, E. Mirza,, B. Sumerkan,, and T. Okten. 2000. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis. Ophthalmic Res. 32:126131.
75. Keren, G.,, A. Alhalel,, E. Bartov,, R. Kitzes-Cohen,, E. Rubinstein,, S. Segev,, and G. Treister. 1991. The intravitreal penetration of orally administered ciprofloxacin in humans. Investig. Ophthalmol. Vis. Sci. 32:23882392.
76. Kestelyn, P.,, J . Bogaerts,, A. M. Stevens,, P. Piot,, and A. Meheus. 1989. Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacin. Am. J. Ophthalmol. 108:516523.
77. Khokhar, S.,, N. Sindhu,, and B. R. Mirdha. 2000. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis. Infection 28:149152.
78. Kim, I. T.,, K. H. Chung,, and B. S. Koo. 1996. Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis. Korean J. Ophthalmol. 10:817.
79. Kim, S. H.,, J. H. Kim,, K. S. Cho,, and J. S. Kwak. 1995. Safety of intravitreally injected ciprofloxacin in phakic rabbit eyes. Korean J. Ophthalmol. 9:1218.
80. Konishi, M.,, M. Yamada,, and Y. Mashima. 1998. Corneal ulcer associated with deposits of norfloxacin. Am. J. Ophthalmol. 125:258260.
81. Kowalski, R. P.,, E. G. Romanowski,, K. A. Yates,, and Y. J. Gordon. 2001. Lomefloxacin is an effective treatment of experimental bacterial keratitis. Cornea 20:306308.
82. Kumar, A.,, M. S. Sridhar,, T. Dada,, H. K. Tewari,, and S. K. Gupta. 2000. Intravitreal pefloxacin therapy in postoperative endophthalmitis. Clin. Exp. Ophthalmol. 28:3840.
83. Lafaix, C.,, A. Salvanet,, A. Fisch,, F. Forestier,, G. Montay,, and A. Meulemans. 1987. [Diffusion of fluoroquinolones in the aqueous humor and crystalline lens]. Pathol. Biol. 35:768771.
84. Leibowitz, H. M. 1991. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am. J. Ophthalmol. 112:34S47S.
85. Liu, W.,, N. Jumbe,, P. Kaw,, G. Drusano,, A. Louie,, and M. H. Miller. 1999. Comparison of quinolone pharmacokinetics in the vitreous humor and CSF following IV drug administration in albino rabbits. Investig. Ophthalmol. Vis. Sci. 40:S88.
86. Liu, W.,, P. Kaw,, M. Vergara,, B. M. Lomaestro,, Q. F. Liu,, M. Mayers,, M. Farber,, G. Drusano,, A. Louie,, and M. H. Miller. 1998. Outcome in rabbits with S. epidermidis endophthalmitis treated with a fluoroquinolne and/or rifampin. Investig. Ophthalmol. Vis. Sci. 39:S357.
87. Liu, W.,, Q. F. Liu,, R. Perkins,, G. Drusano,, A. Louie,, A. Madu,, U. Mian,, M. Mayers,, and M. H. Miller. 1998. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrob. Agents Chemother. 42:14171423.
88. Madu, A. A.,, M. Mayers,, R. Perkins,, W. Liu,, G. L. Drusano,, R. Aswani,, C. N. Madu,, and M. H. Miller. 1996. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. Exp. Eye Res. 63:129136.
89. Maichuk, I.,, E. S. Vakhova,, and L. A. Kononenko. 1998. [Lomefloxacin in treatment of infectious eye diseases]. Antibiot. Khimioter. 43:3235.
90. Malet, F.,, J . Colin,, A. Jauch,, and M. L. Abalain. 1995. Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen. Ophthalmic Res. 27:322329.
91. Mandell, B. A.,, T. A. Meredith,, E. Aguilar,, A. el Massry,, A. Sawant,, and S. Gardner. 1993. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am. J. Ophthalmol. 115:770774.
92. Marchese, A. L.,, V. S. Slana,, E. W. Holmes,, and W. M. Jay. 1993. Toxicity and pharmacokinetics of ciprofloxacin. J. Ocul. Pharmacol. 9:6976.
93. Matsumoto, S.,, and M. E. Stern. 2000. Effect of anti-infective ophthalmic solutions on corneal cells in vitro. Adv. Ther. 17:148151.
94. Maurice , D. M., and S. Mishma,. 1984. Ocular pharmacokinetics, p. 19116. In M. Sears (ed.), Pharmacology of the Eye. Handbook of Experimental Pharmacology. Springer- Verlag, Berlin, Germany.
95. Mayer, D. G. 1987. Overview of toxicological studies. Drugs 34(Suppl. 1):150153.
96. Mayers, M.,, D. Rush,, A. Madu,, M. Motyl,, and M. H. Miller. 1991. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob. Agents Chemother. 35:17911798.
97. Melki, S. A.,, A. Safar,, F. Yaghouti,, P. Scharper,, M. Scharper,, B. Zeligs,, A. L. MacDowell,, M. A. Goldberg,, and J . Lustbader. 2000. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis. Graefe's Arch. Clin. Exp. Ophthalmol. 238:459462.
98. Miller, M. H.,, A. Madu,, G. Samathanam,, D. Rush,, C. N. Madu,, K. Mathisson,, and M. Mayers. 1992. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob. Agents Chemother. 36:3238.
99. Mindel, J. S.,, W. Tasman,, and E. A. Jaeger,. 2000. Pharmacokinetics. In W. Tasman, and E. A. Jaeger (ed.), Duane's Clinical Ophthalmology on CD Rom. Lippincott Williams & Wilkins, Philadelphia, Pa.
100. Moog, E.,, and H. Knothe. 1969. Passage of various tetracyclines into human aqueous humor in dependence of their protien binding in the blood stream. Ber. Zusammenkunf Dtsch. Ophthalmol. Ges. 69:536539.
101. Moreau, J. M.,, L. C. Green,, L. S. Engel,, J. M. Hill,, and R. J . O'Callaghan. 1998. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Curr. Eye Res. 17:808812.
102. Nau, R.,, F. Sorgel,, and H. W. Prange. 1994. Lipophilicity at Ph 7.4 and molecular-size govern the entry of the free serum fraction of drugs into the cerebrospinal-fluid in humans with uninflamed meninges. J. Neurol. Sci. 122:6165.
103. Ng, E.W.,, N. Samiy,, K. L. Ruoff,, F. V. Cousins,, D. C. Hooper,, S. von Gunten,, D. J. D'Amico,, and A. S. Baker. 1998. Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin. Am. J. Ophthalmol. 126:278287.
104. O'Brien, T. P.,, M. R. Sawusch,, J. D. Dick,, and J. D. Gottsch. 1988. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. Arch. Ophthalmol. 106:14441446.
105. Ohkubo, S.,, K. Mochizuki,, M. Torisaki,, Y. Yamashita,, M. Komatsu,, T. Tanahashi,, M. Ogata,, and T. Kajimura. 1996. [Effects of intravitreal levofloxacin on the rabbit retina]. Nippon Ganka Gakkai Zasshi 100:592598.
106. Okhravi, N.,, H. M. Towler,, P. Hykin,, M. Matheson,, and S. Lightman. 1997. Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. Br. J. Ophthalmol. 81:719725.
107. Oldendorf, W. H. 1973. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am. J. Physiol 224:14501453.
108. Ooishi, M.,, and Miyao, M. 1990. Ocular pharmacokinetic studies on AT-4140, abstr. 1258. In Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
109. Ooishi, M.,, M. Miyao,, T. Abe,, T. Sasagawa,, M. Motoyama,, T. Nakagawa,, and T. Okutomi. 1995. [Pharmacokinetics of balofloxacin in the intraocular tissues of pigmented rabbits]. Jpn. J. Antibiot. 48:12741280.
110. Ooishi, M.,, F. Sakaue,, A. Oonomo,, and K. Yoneyama. 1985. Fundamental and clinical studies on Bay o 9867 in ophthalmology. Chemotherapy (Tokyo) 33:10141021.
111. Ozturk, F.,, S. Kortunay,, E. Kurt,, S. S. Ilker,, N. E. Basci,, and A. Bozkurt. 1999. Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes. Retina 19:218222.
112. Ozturk, F.,, S. Kortunay,, E. Kurt,, S. S. Ilker,, U. U. Inan,, N. E. Basci,, A. Bozkurt,, and O. Kayaalp. 1999. Effects of trauma and infection on ciprofloxacin levels in the vitreous cavity. Retina 19:127130.
113. Ozturk, F.,, S. Kortunay,, E. Kurt,, U. U. Inan,, S. S. Ilker,, N. Basci,, and A. Bozkurt. 1999. The effect of long-term use and inflammation on the ocular penetration of topical ofloxacin. Curr. Eye Res. 19:461464.
114. Ozturk, F.,, S. Kortunay,, E. Kurt,, I. U. Ubeyt,, I. S. Sami,, N. E. Basci,, A. Bozkurt,, and K. S. Oguz. 1999. Ofloxacin levels after intravitreal injection. Effects of trauma and inflammation. Ophthalmic Res. 31:446451.
115. Ozturk, F.,, E. Kurt,, U. U. Inan,, M. C. Kortunay,, S. S. Ilker,, N. E. Basci,, and A. Bozkurt. 2000. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. Int. J. Pharm. 204:9195.
116. Ozturk, F.,, E. Kurt,, U. U. Inan,, S. Kortunay,, S. S. Ilker,, N. E. Basci,, and A. Bozkurt. 2000. The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin. Int. J. Pharm. (Amst.) 204:97100.
117. Parkkari, M.,, H. Paivarinta,, and L. Salminen. 1995. The treatment of endophthalmitis after cataract surgery: review of 26 cases.J. Ocul. Pharmacol. Ther. 11:349359.
118. Perkins, R. J.,, W. Liu,, G. Drusano,, A. Madu,, M. Mayers,, C. Madu,, and M. H. Miller. 1995. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents Chemother. 39:14931498.
119. Preston, K. E.,, M. A. Kacica,, R. J. Limberger,, W. A. Archinal,, and R. A. Venezia. 1997. The resistance and integrase genes of pACMl, a conjugative multiple-resistance plasmid, from Klebsiella oxytoca. Plasmid 37:105118.
120. Preston, S. L.,, G. L. Drusano,, A. L. Berman,, C. L. Fowler,, A. T. Chow,, B. Dornseif,, V. Reichl,, J. Natarajan,, and M. Corrado. 1998. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279:125129.
121. Rabkin, M. D.,, M. B. Bellhorn,, and R. W. Bellhorn. 1977. Selected molecular weight dextrans for in vivo permeability studies of rat retinal vascular disease. Exp. Eye Res. 24:607612.
122. Reidy, J. J.,, J. A. Hobden,, J. M. Hill,, K. Forman,, and R. J. O'Callaghan. 1991. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 10:2528.
123. Richman, J.,, H. Zolezio,, and D. Tang-Liu. 1990. Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms. Antimicrob. Agents Chemother. 34:16021604.
124. Rootman, D. S.,, P. Savage,, S. M. Hasany,, L. Chisholm,, and P. K. Basu. 1992. Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes. Can. J. Ophthalmol. 27:277282.
125. Salminen, L. 1978. Cloxacillin distribution in the rabbit eye after intravenous injection. Acta Ophthalmol. 56:1119.
126. Schentag, J. J.,, L. C. Strenkoski-Nix,, D. E. Nix,, and A. Forrest. 1998. Pharmacodynamic interactions of antibiotics alone and in combination. Clin. Infect. Dis. 27:4046.
127. Schluter, G. 1987. Ciprofloxacin: review of toxicologic effects. Am. J. Med. 82:9193.
128. Shimoda, K.,, S. Okawara,, and M. Kato. 2001. Phototoxic retinal degeneration and toxicokinetics of sitafloxacin, a quinolone antibacterial agent, in mice. Arch. Toxicol. 75:395399.
129. Shimoda, K.,, M. Yoshida,, N. Wagai,, S. Takayama,, and M. Kato. 1993. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice. Toxicol. Pathol. 21:554561.
130. Silbiger, J.,, and G. A. Stern. 1992. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental pseudomonas keratitis. Ophthalmology 99:889892.
131. Skoutelis, A. T.,, S. P. Gartaganis,, C. J . Chrysanthopoulos,, D. Beermann,, C. Papachristou,, and H. P. Bassaris. 1988. Aqueous humor penetration of ciprofloxacin in the human eye. Arch. Ophthalmol. 106:404405.
132. Stevens, S. X.,, B. D. Fouraker,, and H. G. Jensen. 1991. Intraocular safety of ciprofloxacin. Arch. Ophthalmol. 109:17371743.
133. Sugar, A.,, M. A. Cohen,, P. A. Bien,, T. J. Griffin,, C. L. Heifetz,, and S. Mehta. 1986. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic. Arch. Ophthalmol. 104:12301232.
134. Sweeney, G.,, A. I. Fern,, G. Lindsay,, and M. W. Doig. 1990. Penetration of ciprofloxacin into the aqueous humour of the uninflamed human eye after oral administration. J. Antimicrob. Chemother. 26:99105.
135. Tanahashi, T.,, K. Mochizuki,, M. Torisaki,, Y. Yamashita,, M. Komatsu,, T. Higashide,, and M. Ogata. 1992. Effect of intravitreal injection of norfloxacin on the retina in pigmented rabbits. Lens Eye Toxic. Res. 9:493503.
136. Tang-Liu, D.,, J . Lambert,, S. Blancaflor,, and A. Gwon. 1995. Availability of 0.3% ofloxacin ointment and solution in human conjunctiva and aqueous humor.J. Ocul. Pharmacol. Ther. 11:5763.
137. Tsai, A.C.,, M. C. Tseng,, S. W. Chang,, and F. R. Hu. 1995. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J . Formos. Med. Assoc. 94:760764.
138. van de Waterbeemd, H.,, G. Camenisch,, G. Folkers,, J. R. Chretien,, and O. A. Raevsky. 1998. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Targeting 6:151165.
139. Verbraeken, H.,, A. Verstraete,, V. D. Van,, and G. Verschraegen. 1996. Penetration of gentamicin and ofloxacin in human vitreous after systemic administration. Graefe's Arch. Clin. Exp. Ophthalmol. 234(Suppl. 1):S59S65.
140. von Keyserlingk, J.,, R. Beck,, U. Fischer,, E. M. Hehl,, R. Guthoff,, and B. Drewelow. 1997. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes. Eur. J. Clin. Pharmacol. 53:251255.
141. Waga, J.,, I. Nilsson-Ehle,, B. Ljungberg,, A. Skarin,, L. Stahle,, and B. Ehinger. 1999. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J . Ocul. Pharmacol. Ther. 15:55463.
142. Wegener, A.,, U. D. Kuhn,, M. Lorenz,, and O. Hockwin. 1990. Evaluation of a possible cocataractogenic potential of ofloxacin. Lens Eye Toxic. Res. 7:3947.
143. Wiechens, B.,, J. B. Grammer,, U. Johannsen,, U. Pleyer,, J . Hedderich,, and G. I. Duncker. 1999. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 213:120128.
144. Wiechens, B.,, D. Neumann,, J. B. Grammer,, U. Pleyer,, J . Hedderich,, and G. I. Duncker. 1998. Retinal toxicity of liposome- incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Int. Ophthalmol. 22:133143.
145. Yoshida, A.,, S. Ishiko,, and M. Kojima. 1992. Outward permeability of the blood-retinal barrier. Graefe's Arch. Clin. Exp. Ophthalmol. 230:7883.

Tables

Generic image for table
Table 2

Ocular penetration after systemic administration in rabbits

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18
Generic image for table
Table 1

Concentrations of quinolones after topical application in rabbits

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18
Generic image for table
Table 3

Concentrations of quinolones after topical application in humans

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18
Generic image for table
Table 4

Penetration of quinolones other than ciprofloxacin into the human eye following systemic drug administration

Citation: Miller M, Mayers M. 2003. Treatment of Eye Infections, p 291-309. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch18

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error